The landscape of dementia analysis has developed dramatically with the advent of complex biomarkers, including amyloid PET scans, tau imaging, and blood-primarily based exams that could detect Alzheimer's pathology yrs before signs and symptoms emerge. Although these technological improvements characterize extraordinary development in understanding